The Doxorubicin-Induced G2/M Arrest in Breast Cancer Cells Modulated by Natural Compounds Naringenin and Hesperidin

Doxorubicin as the common drug for breast cancer has been widely proposed to use in combine with a natural compound in order to overcome its side effects such as cardiotoxicity and resistance. Previously, we reported that naringenin and hesperidin, the abundant flavanons in citrus fruit peel, increa...

Full description

Bibliographic Details
Main Authors: Sendy Junedi, Adam Hermawan, Aditya Fitriasari, Agustina Setiawati, Ratna Asmah Susidarti, Edy Meiyanto
Format: Article
Language:English
Published: Indonesian Society for Cancer Chemoprevention 2021-10-01
Series:ISCC (Indonesian Journal of Cancer Chemoprevention)
Online Access:https://ijcc.chemoprev.org/index.php/ijcc/article/view/338
_version_ 1818251084864421888
author Sendy Junedi
Adam Hermawan
Aditya Fitriasari
Agustina Setiawati
Ratna Asmah Susidarti
Edy Meiyanto
author_facet Sendy Junedi
Adam Hermawan
Aditya Fitriasari
Agustina Setiawati
Ratna Asmah Susidarti
Edy Meiyanto
author_sort Sendy Junedi
collection DOAJ
description Doxorubicin as the common drug for breast cancer has been widely proposed to use in combine with a natural compound in order to overcome its side effects such as cardiotoxicity and resistance. Previously, we reported that naringenin and hesperidin, the abundant flavanons in citrus fruit peel, increased cytotoxic and apoptosis activities of doxorubicin in doxorubicin resistant breast cancer cells (T47D and MCF-7 cells). Since doxorubicin arrests G2/M phase in most cancer cells, both flavanons are speculated to affect the similar phase in breast cancer cells. Cell cycle distributions were determined by flowcytometry using propidium iodide (PI) to stain DNA of the cells. Combination of naringenin or hesperidin with doxorubicin increased accumulation of T47D cells in G2/M phase, while in MCF-7 cells, accumulated cells in G2/M phase were decreased, accompanying with slightly increased in G1 phase. Naringenin itself had no effect on cell cycle of both cells. Whereas, hesperidin arrested G2/M and G1 phases in T47D and MCF-7 cells, respectively. The different effect of naringenin and hesperidin in T47D and MCF-7 cells is most likely caused by difference of p53 status. In p53 mutant, T47D cells, naringenin and hesperidin supported mechanism of doxorubicin to arrest at G2/M that to be considered via p53-independent pathway. Whereas, in p53 wild-type MCF-7 cells, naringenin and hesperidin decreased G2/M arrest, suggesting that both flavanons do not utilize cell cycle arrest for their anticancer activity with doxorucibin. This study revealed that potential co-chemoterapeutic agents, naringenin and hesperidin distinctly modulated cell cycle arrest induced by doxorubicin according to the characteristic of breast cancer cells. Keywords: naringenin, hesperidin, doxorubicin, cell cycle, breast cancer cells.
first_indexed 2024-12-12T16:02:40Z
format Article
id doaj.art-ffda2d45bdb140dd801177a2ed5b0059
institution Directory Open Access Journal
issn 2088-0197
2355-8989
language English
last_indexed 2024-12-12T16:02:40Z
publishDate 2021-10-01
publisher Indonesian Society for Cancer Chemoprevention
record_format Article
series ISCC (Indonesian Journal of Cancer Chemoprevention)
spelling doaj.art-ffda2d45bdb140dd801177a2ed5b00592022-12-22T00:19:23ZengIndonesian Society for Cancer ChemopreventionISCC (Indonesian Journal of Cancer Chemoprevention)2088-01972355-89892021-10-01122838910.14499/indonesianjcanchemoprev12iss2pp83-89223The Doxorubicin-Induced G2/M Arrest in Breast Cancer Cells Modulated by Natural Compounds Naringenin and HesperidinSendy Junedi0Adam Hermawan1Aditya Fitriasari2Agustina Setiawati3Ratna Asmah Susidarti4Edy Meiyanto5Cancer Chemoprevention Research Center, Faculty of Pharmacy, Universitas Gadjah MadaCancer Chemoprevention Research Center, Faculty of Pharmacy, Universitas Gadjah MadaCancer Chemoprevention Research Center, Faculty of Pharmacy, Universitas Gadjah MadaFaculty of Pharmacy, Universitas Sanata Dharma, YogyakartaDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Universitas Gadjah MadaDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Universitas Gadjah MadaDoxorubicin as the common drug for breast cancer has been widely proposed to use in combine with a natural compound in order to overcome its side effects such as cardiotoxicity and resistance. Previously, we reported that naringenin and hesperidin, the abundant flavanons in citrus fruit peel, increased cytotoxic and apoptosis activities of doxorubicin in doxorubicin resistant breast cancer cells (T47D and MCF-7 cells). Since doxorubicin arrests G2/M phase in most cancer cells, both flavanons are speculated to affect the similar phase in breast cancer cells. Cell cycle distributions were determined by flowcytometry using propidium iodide (PI) to stain DNA of the cells. Combination of naringenin or hesperidin with doxorubicin increased accumulation of T47D cells in G2/M phase, while in MCF-7 cells, accumulated cells in G2/M phase were decreased, accompanying with slightly increased in G1 phase. Naringenin itself had no effect on cell cycle of both cells. Whereas, hesperidin arrested G2/M and G1 phases in T47D and MCF-7 cells, respectively. The different effect of naringenin and hesperidin in T47D and MCF-7 cells is most likely caused by difference of p53 status. In p53 mutant, T47D cells, naringenin and hesperidin supported mechanism of doxorubicin to arrest at G2/M that to be considered via p53-independent pathway. Whereas, in p53 wild-type MCF-7 cells, naringenin and hesperidin decreased G2/M arrest, suggesting that both flavanons do not utilize cell cycle arrest for their anticancer activity with doxorucibin. This study revealed that potential co-chemoterapeutic agents, naringenin and hesperidin distinctly modulated cell cycle arrest induced by doxorubicin according to the characteristic of breast cancer cells. Keywords: naringenin, hesperidin, doxorubicin, cell cycle, breast cancer cells.https://ijcc.chemoprev.org/index.php/ijcc/article/view/338
spellingShingle Sendy Junedi
Adam Hermawan
Aditya Fitriasari
Agustina Setiawati
Ratna Asmah Susidarti
Edy Meiyanto
The Doxorubicin-Induced G2/M Arrest in Breast Cancer Cells Modulated by Natural Compounds Naringenin and Hesperidin
ISCC (Indonesian Journal of Cancer Chemoprevention)
title The Doxorubicin-Induced G2/M Arrest in Breast Cancer Cells Modulated by Natural Compounds Naringenin and Hesperidin
title_full The Doxorubicin-Induced G2/M Arrest in Breast Cancer Cells Modulated by Natural Compounds Naringenin and Hesperidin
title_fullStr The Doxorubicin-Induced G2/M Arrest in Breast Cancer Cells Modulated by Natural Compounds Naringenin and Hesperidin
title_full_unstemmed The Doxorubicin-Induced G2/M Arrest in Breast Cancer Cells Modulated by Natural Compounds Naringenin and Hesperidin
title_short The Doxorubicin-Induced G2/M Arrest in Breast Cancer Cells Modulated by Natural Compounds Naringenin and Hesperidin
title_sort doxorubicin induced g2 m arrest in breast cancer cells modulated by natural compounds naringenin and hesperidin
url https://ijcc.chemoprev.org/index.php/ijcc/article/view/338
work_keys_str_mv AT sendyjunedi thedoxorubicininducedg2marrestinbreastcancercellsmodulatedbynaturalcompoundsnaringeninandhesperidin
AT adamhermawan thedoxorubicininducedg2marrestinbreastcancercellsmodulatedbynaturalcompoundsnaringeninandhesperidin
AT adityafitriasari thedoxorubicininducedg2marrestinbreastcancercellsmodulatedbynaturalcompoundsnaringeninandhesperidin
AT agustinasetiawati thedoxorubicininducedg2marrestinbreastcancercellsmodulatedbynaturalcompoundsnaringeninandhesperidin
AT ratnaasmahsusidarti thedoxorubicininducedg2marrestinbreastcancercellsmodulatedbynaturalcompoundsnaringeninandhesperidin
AT edymeiyanto thedoxorubicininducedg2marrestinbreastcancercellsmodulatedbynaturalcompoundsnaringeninandhesperidin
AT sendyjunedi doxorubicininducedg2marrestinbreastcancercellsmodulatedbynaturalcompoundsnaringeninandhesperidin
AT adamhermawan doxorubicininducedg2marrestinbreastcancercellsmodulatedbynaturalcompoundsnaringeninandhesperidin
AT adityafitriasari doxorubicininducedg2marrestinbreastcancercellsmodulatedbynaturalcompoundsnaringeninandhesperidin
AT agustinasetiawati doxorubicininducedg2marrestinbreastcancercellsmodulatedbynaturalcompoundsnaringeninandhesperidin
AT ratnaasmahsusidarti doxorubicininducedg2marrestinbreastcancercellsmodulatedbynaturalcompoundsnaringeninandhesperidin
AT edymeiyanto doxorubicininducedg2marrestinbreastcancercellsmodulatedbynaturalcompoundsnaringeninandhesperidin